PHARMIGENE, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.95 TWD | -0.29% |
|
-2.02% | -18.12% |
| 30/04 | Pharmigene, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | Pharmigene, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Quotes 5-day view
End-of-day quote Taipei Exchange| 03/06/2024 | 04/06/2024 | 05/06/2024 | 06/06/2024 | 07/06/2024 | |
|---|---|---|---|---|---|
| Last | 17.45 NT$ | 17.05 NT$ | 17.5 NT$ | 17 NT$ | 16.95 NT$ |
| Volume | 33 140 | 11 000 | 25 000 | 30 828 | 3 000 |
| Change | +0.87% | -2.29% | +2.64% | -2.86% | -0.29% |
| Opening | 17.50 | 17.10 | 17.45 | 17.10 | 16.95 |
| High | 17.50 | 17.20 | 17.60 | 17.25 | 16.95 |
| Low | 17.10 | 17.05 | 17.45 | 17.00 | 16.95 |
Performance
| 1 day | -0.29% | ||
| 1 week | -2.02% | ||
| Current month | -2.02% | ||
| 1 month | -10.79% | ||
| 3 months | -16.71% | ||
| 6 months | -25.00% | ||
| Current year | -18.12% | ||
| 1 year | -24.83% | ||
| 3 years | -29.67% |
Volumes
marketsDaily volume
3 000
Avg. Volume 20 sessions
16 366
Avg. Volume 20 sessions TWD
277 403.70
Avg. Volume 20 sessions USD
8 562.07
Record volume 1
4 122 707
Record volume 2
3 695 338
Record volume 3
3 570 000
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (TWD)
854 304 811
Capitalization (USD)
26 368 118
Net sales (TWD)
132 707 000
Net sales (USD)
4 096 002
Free-Float
49.29 %
Free-Float capitalization (TWD)
421 100 748
Free-Float capitalization (USD)
12 997 275
Average Daily Capital Traded
0.03%
Highs and lows
1 week
16.95
17.60
1 month
16.9518.80
Current year
16.9521.10
1 year
16.9525.70
3 years
13.4025.70
5 years
13.4036.00
10 years
13.4036.00
Indicators
Moving average 5 days
17.19
Moving average 20 days
17.59
Moving average 50 days
18.68
Moving average 100 days
19.57
Price spread / (MMA5)
+1.42%
Price spread / (MMA20)
+3.78%
Price spread / (MMA50)
+10.21%
Price spread / (MMA100)
+15.46%
STIM
RSI 9 days
34.24
RSI 14 days
34.68
Sector Comparison - Bio Diagnostics & Testing
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -0.29% | -2.02% | -18.12% | -24.83% | 2.64Cr | ||
| -3.90% | -5.54% | -41.97% | -51.08% | 792.19Cr | ||
| -1.21% | +5.79% | +5.99% | -12.70% | 350.83Cr | ||
| -4.42% | -12.39% | -4.31% | -5.58% | 217.71Cr | ||
| -0.79% | -4.25% | -21.69% | -34.01% | 196.83Cr | ||
| -3.55% | -0.48% | -24.94% | -21.90% | 157.87Cr | ||
| +1.77% | -0.69% | +31.45% | -38.46% | 114.37Cr | ||
| -1.36% | +16.91% | +26.75% | +81.29% | 79Cr | ||
| -0.48% | -2.36% | -9.83% | -16.06% | 69Cr | ||
| -7.44% | +4.64% | -26.33% | -52.75% | 53Cr | ||
| +4.73% | +10.64% | +3.38% | - | 30Cr | ||
| -0.96% | -3.72% | -16.34% | -39.25% | 16Cr | ||
| +0.10% | -0.31% | -27.66% | -40.18% | 16Cr | ||
| +1.19% | +2.63% | +20.81% | +15.93% | 13Cr | ||
| -0.57% | +1.87% | -11.22% | -11.90% | 12Cr | ||
| -2.90% | -1.96% | -13.33% | -32.30% | 9.74Cr | ||
| Average | -1.25% | +0.61% | -7.96% | -18.92% | ||
| Weighted average by Cap. | -2.54% | -1.86% | -17.50% | -28.44% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -18.12% | ||
| 2023 | +4.28% | ||
| 2022 | -8.53% | ||
| 2021 | -13.20% | ||
| 2020 | +0.40% |
- Stock Market
- Equities
- 7595 Stock
- Quotes Pharmigene, Inc.
